{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:48Z","timestamp":1791843228101,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T00:00:00Z","timestamp":1459036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>\u2003<\/jats:title><jats:p>Sclerostin is involved in the regulation of osteoblastogenesis and little is known about its role in the development of bone disease in primary biliary cirrhosis (PBC), characterized by low bone formation. Therefore, we have assessed the circulating levels and the liver expression of sclerostin in this cholestatic disease. Serum sclerostin levels were measured in 79 women with PBC (mean age 60.6\u2009\u00b1\u20091.2 years) and in 80 control women. Lumbar and femoral bone mineral density (BMD), as well as parameters of mineral metabolism and bone remodeling, were measured. Moreover, sclerostin gene (SOST) expression in the liver was assessed by real-time PCR in samples of liver tissue taken by biopsy in 11 PBC patients and in 5 normal liver specimens. Presence and distribution of sclerostin was evaluated in liver slices from 11 patients by immunohistochemistry. The severity of histologic lesions was assessed semiquantitatively in the same liver samples. PBC patients had higher sclerostin levels than controls (75.6\u2009\u00b1\u20093.9 versus 31.7\u2009\u00b1\u20091.6\u2009pmol\/L, p\u2009&amp;lt;\u20090.001). Serum sclerostin correlated inversely with markers of bone formation and resorption. Sclerostin mRNA in the liver was overexpressed compared with control samples (2.7-fold versus healthy liver). Sclerostin was detected by immunohistochemistry in 7 of the 11 liver samples, mainly located in the bile ducts. Liver sclerostin was associated with the severity of cholangitis (p\u2009=\u20090.02) and indirectly with the degree of lobular inflammation (p\u2009=\u20090.03). Sclerostin mRNA expression was higher in samples that tested positive by immunohistochemistry and particularly in those with lobular granuloma (p\u2009=\u20090.02). The increased expression of sclerostin in the liver and the association with histologic cholangitis may explain the high serum levels of this protein in patients with PBC, thus suggesting that sclerostin may influence the decreased bone formation in this cholestatic disease. \u00a9 2016 American Society for Bone and Mineral Research.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jbmr.2845","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T03:37:25Z","timestamp":1459136245000},"page":"1725-1733","source":"Crossref","is-referenced-by-count":35,"title":["Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis"],"prefix":"10.1093","volume":"31","author":[{"given":"N\u00faria","family":"Gua\u00f1abens","sequence":"first","affiliation":[{"name":"Center for Biomedical Research Network in Hepatic and Digestive Diseases (CIBERehd)Hospital Cl\u00ednicBarcelonaSpain"},{"name":"Department of RheumatologyMetabolic Bone Diseases Unit, Hospital Cl\u00ednic, Barcelona, IDIBAPS, University of BarcelonaBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ruiz-Gasp\u00e0","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research Network in Hepatic and Digestive Diseases (CIBERehd)Hospital Cl\u00ednicBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Gifre","sequence":"additional","affiliation":[{"name":"Department of RheumatologyMetabolic Bone Diseases Unit, Hospital Cl\u00ednic, Barcelona, IDIBAPS, University of BarcelonaBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Miquel","sequence":"additional","affiliation":[{"name":"Pathology DepartmentHospital Cl\u00ednicBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Peris","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research Network in Hepatic and Digestive Diseases (CIBERehd)Hospital Cl\u00ednicBarcelonaSpain"},{"name":"Department of RheumatologyMetabolic Bone Diseases Unit, Hospital Cl\u00ednic, Barcelona, IDIBAPS, University of BarcelonaBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Monegal","sequence":"additional","affiliation":[{"name":"Department of RheumatologyMetabolic Bone Diseases Unit, Hospital Cl\u00ednic, Barcelona, IDIBAPS, University of BarcelonaBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dubrueil","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research Network in Hepatic and Digestive Diseases (CIBERehd)Hospital Cl\u00ednicBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Arias","sequence":"additional","affiliation":[{"name":"Department of RheumatologyMetabolic Bone Diseases Unit, Hospital Cl\u00ednic, Barcelona, IDIBAPS, University of BarcelonaBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic, Barcelona, IDIBAPS, University of BarcelonaBarcelonaSpain"},{"name":"Center for Biomedical Research Network in Hepatic and Digestive Diseases (CIBERehd)Hospital Cl\u00ednicBarcelonaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,27]]},"reference":[{"key":"2024021014172630100_jbmr2845-bib-0001","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2010.05.030","article-title":"Liver and bone","volume":"503","author":"Gua\u00f1abens","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"2024021014172630100_jbmr2845-bib-0002","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"J Hepatol"},{"key":"2024021014172630100_jbmr2845-bib-0003","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Gua\u00f1abens","year":"2010","journal-title":"Gastroenterology"},{"key":"2024021014172630100_jbmr2845-bib-0004","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/jhep.2002.36357","article-title":"Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry","volume":"36","author":"Guichelaar","year":"2002","journal-title":"Hepatology"},{"key":"2024021014172630100_jbmr2845-bib-0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-001-2028-4","article-title":"High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation","volume":"69","author":"Ninkovic","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"2024021014172630100_jbmr2845-bib-0006","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Gua\u00f1abens","year":"2005","journal-title":"J Hepatol"},{"key":"2024021014172630100_jbmr2845-bib-0007","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00774-007-0833-1","article-title":"Primary biliary cirrhosis and osteoporosis: a case-control study","volume":"26","author":"Mounach","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"2024021014172630100_jbmr2845-bib-0008","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","article-title":"Bone loss and reduced osteoblast function in primary biliary cirrhosis","volume":"103","author":"Hodgson","year":"1985","journal-title":"Ann Intern Med"},{"key":"2024021014172630100_jbmr2845-bib-0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.1840070127","article-title":"Low bone turnover state in primary biliary cirrhosis","volume":"7","author":"Stellon","year":"1987","journal-title":"Hepatology"},{"key":"2024021014172630100_jbmr2845-bib-0010","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1359\/jbmr.2003.18.12.2190","article-title":"Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease","volume":"18","author":"Guichelaar","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024021014172630100_jbmr2845-bib-0011","first-page":"1356","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis","volume":"85","author":"Gua\u00f1abens","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"2024021014172630100_jbmr2845-bib-0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1359\/jbmr.1998.13.4.731","article-title":"Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis","volume":"13","author":"Gua\u00f1abens","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024021014172630100_jbmr2845-bib-0013","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1210\/jcem-64-5-873","article-title":"Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis","volume":"64","author":"Fonseca","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014172630100_jbmr2845-bib-0014","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/hep.24605","article-title":"Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases","volume":"54","author":"Ruiz-Gasp\u00e0","year":"2011","journal-title":"Hepatology"},{"key":"2024021014172630100_jbmr2845-bib-0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/liv.12153","article-title":"Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells","volume":"33","author":"Dubreuil","year":"2013","journal-title":"Liver Int"},{"key":"2024021014172630100_jbmr2845-bib-0016","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"key":"2024021014172630100_jbmr2845-bib-0017","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"Wnt signalling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"key":"2024021014172630100_jbmr2845-bib-0018","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/\u00df-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"2024021014172630100_jbmr2845-bib-0019","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J Clin Invest"},{"key":"2024021014172630100_jbmr2845-bib-0020","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"2024021014172630100_jbmr2845-bib-0021","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J"},{"key":"2024021014172630100_jbmr2845-bib-0022","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J Exp Med"},{"key":"2024021014172630100_jbmr2845-bib-0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbmr.2154","article-title":"Insights into the mechanisms of sclerostin action in regulating bone mass accrual","volume":"29","author":"Williams","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2024021014172630100_jbmr2845-bib-0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2024021014172630100_jbmr2845-bib-0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2024021014172630100_jbmr2845-bib-0026","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1074\/mcp.M110.001693","article-title":"Proteomics characterization of extracellular space components in the human aorta","volume":"9","author":"Didangelos","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"2024021014172630100_jbmr2845-bib-0027","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","article-title":"Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study","volume":"14","author":"Brandenburg","year":"2013","journal-title":"BMC Nephrol"},{"key":"2024021014172630100_jbmr2845-bib-0028","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014172630100_jbmr2845-bib-0029","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/dc12-1691","article-title":"Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels","volume":"36","author":"Morales-Santana","year":"2013","journal-title":"Diabetes Care"},{"key":"2024021014172630100_jbmr2845-bib-0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","article-title":"The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women","volume":"56","author":"Hampson","year":"2013","journal-title":"Bone"},{"key":"2024021014172630100_jbmr2845-bib-0031","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bone.2015.11.008","article-title":"Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease","volume":"83","author":"Kim","year":"2015","journal-title":"Bone"},{"key":"2024021014172630100_jbmr2845-bib-0032","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/alcalc\/ags136","article-title":"Serum sclerostin in alcoholics: a pilot study","volume":"48","author":"Gonz\u00e1lez-Reimers","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"2024021014172630100_jbmr2845-bib-0033","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00774-013-0524-z","article-title":"Effect of liver dysfunction on circulating sclerostin","volume":"32","author":"Rhee","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"2024021014172630100_jbmr2845-bib-0034","first-page":"1","year":"1994"},{"key":"2024021014172630100_jbmr2845-bib-0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2024021014172630100_jbmr2845-bib-0036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"2024021014172630100_jbmr2845-bib-0037","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2559.2006.02537.x","article-title":"Proposal of a new staging and grading system of the liver for primary biliary cirrhosis","volume":"49","author":"Hiramatsu","year":"2006","journal-title":"Histopathology"},{"key":"2024021014172630100_jbmr2845-bib-0038","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J Clin Invest"},{"key":"2024021014172630100_jbmr2845-bib-0039","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2015.01.030","article-title":"Increased serum sclerostin in postoperative biliary atresia","volume":"442","author":"Honsawek","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2024021014172630100_jbmr2845-bib-0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"M\u00f6dder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024021014172630100_jbmr2845-bib-0041","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bonekey.2013.95","article-title":"Clinical utility of serum sclerostin measurements","volume":"2","author":"Clarke","year":"2013","journal-title":"BoneKEy Reports"},{"key":"2024021014172630100_jbmr2845-bib-0042","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-012-1978-x","article-title":"Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study","volume":"24","author":"Garnero","year":"2013","journal-title":"Osteoporos Int"},{"key":"2024021014172630100_jbmr2845-bib-0043","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-3419","article-title":"Serum sclerostin and risk of hip fracture in older Caucasian women","volume":"97","author":"Arasu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014172630100_jbmr2845-bib-0044","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00198-010-1525-6","article-title":"Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide","volume":"23","author":"Polyzos","year":"2012","journal-title":"Osteoporos Int"},{"key":"2024021014172630100_jbmr2845-bib-0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bone.2014.06.037","article-title":"Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis","volume":"67","author":"Gatti","year":"2014","journal-title":"Bone"},{"key":"2024021014172630100_jbmr2845-bib-0046","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2012-4039","article-title":"Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis","volume":"98","author":"Catalano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014172630100_jbmr2845-bib-0047","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014172630100_jbmr2845-bib-0048","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-10-0699","article-title":"Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls","volume":"163","author":"van Lierop","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024021014172630100_jbmr2845-bib-0049","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2011-0254","article-title":"Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays","volume":"96","author":"McNulty","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014172630100_jbmr2845-bib-0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00198-014-2635-3","article-title":"Comparison of two commercially available ELISAs for circulating sclerostin","volume":"25","author":"Costa","year":"2014","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2845","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.2845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.2845","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/9\/1725\/56649240\/jbmr2845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/9\/1725\/56649240\/jbmr2845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:14:01Z","timestamp":1748823241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/31\/9\/1725-1733\/7605158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,27]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,3,27]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2845","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9,1]]},"published":{"date-parts":[[2016,3,27]]}}}